Carcinoma, Transitional Cell

Showing 1 - 24 of 24

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Urothelial Carcinoma, Urothelial Carcinoma Recurrent, Urothelial Carcinoma Ureter Trial (Jelmyto (mitomycin) for pyelocalyceal

Not yet recruiting
  • Urothelial Carcinoma
  • +7 more
  • Jelmyto (mitomycin) for pyelocalyceal solution
  • (no location specified)
May 22, 2023

Carcinoma, Transitional Cell, Urinary Bladder Tumors, Urologic Tumors Trial in Worldwide (enfortumab vedotin (EV),

Active, not recruiting
  • Carcinoma, Transitional Cell
  • +6 more
  • enfortumab vedotin (EV)
  • +4 more
  • Anchorage, Alaska
  • +105 more
Dec 19, 2022

Carcinoma, Transitional Cell Trial in Worldwide (Atezolizumab)

Terminated
  • Carcinoma, Transitional Cell
  • Scottsdale, Arizona
  • +185 more
Jun 13, 2022

Carcinoma, Transitional Cell Trial in San Francisco (Atezolizumab)

Active, not recruiting
  • Carcinoma, Transitional Cell
  • San Francisco, California
    University of California, San Francisco
May 24, 2022

Carcinoma, Transitional Cell, HER-2 Gene Amplification Trial in Beijing (Trastuzumab)

Recruiting
  • Carcinoma, Transitional Cell
  • HER-2 Gene Amplification
  • Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
Mar 31, 2022

Carcinoma, Transitional Cell Trial in Worldwide (Rogaratinib (BAY1163877), Chemotherapy)

Completed
  • Carcinoma, Transitional Cell
  • Anchorage, Alaska
  • +160 more
Feb 11, 2022

HER2-positive, Adenocarcinoma, Bile Duct Cancer Trial in United States (CT-0508)

Recruiting
  • HER2-positive
  • +30 more
  • CT-0508
  • Duarte, California
  • +4 more
Feb 1, 2022

Carcinoma, Transitional Cell Trial in Beijing (nanoparticle albumin-bound paclitaxel, S-1, Gemcitabine, cisplatin)

Completed
  • Carcinoma, Transitional Cell
  • nanoparticle albumin-bound paclitaxel, S-1
  • Gemcitabine, cisplatin
  • Beijing, China
    Chinese PLA General Hospital
Aug 5, 2021

Carcinoma, Transitional Cell Trial in Orange (Oxaliplatin with Gemcitabine)

Terminated
  • Carcinoma, Transitional Cell
  • Oxaliplatin with Gemcitabine
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Apr 9, 2021

Carcinoma, Transitional Cell, Transitional Cell Carcinoma of Renal Pelvis Trial in Israel, United States (UGN-101 instillations)

Completed
  • Carcinoma, Transitional Cell
  • Transitional Cell Carcinoma of Renal Pelvis
  • UGN-101 instillations
  • Phoenix, Arizona
  • +23 more
Dec 1, 2020

Carcinoma, Transitional Cell, Bladder Cancer, Bladder Tumor Trial in Worldwide (Pralatrexate Injection, Vitamin B12, Folic Acid)

Completed
  • Carcinoma, Transitional Cell
  • +2 more
  • Pralatrexate Injection
  • +2 more
  • Tucson, Arizona
  • +18 more
Dec 10, 2019

Urinary Bladder Tumors, Carcinoma, Transitional Cell, Ovarian Tumors Trial in Worldwide (CC-486, Carboplatin, ABI-007)

Completed
  • Urinary Bladder Neoplasms
  • +7 more
  • Scottsdale, Arizona
  • +12 more
Nov 7, 2019

Carcinoma, Transitional Cell Trial in Spain (Vinflunine, Undefined (standard care))

Completed
  • Carcinoma, Transitional Cell
  • Elda, Alicante, Spain
  • +19 more
Apr 2, 2019

Breast Cancer, Ovarian Epithelial Cancer Recurrent, Sarcoma Trial in United States (Mifepristone and Eribulin in combination)

Completed
  • Breast Cancer
  • +6 more
  • Mifepristone and Eribulin in combination
  • Tucson, Arizona
  • +10 more
Jan 12, 2018

Carcinoma, Transitional Cell Trial in New York, Philadelphia, Rome (Tesetaxel)

Unknown status
  • Carcinoma, Transitional Cell
  • New York, New York
  • +2 more
Jul 9, 2012

Cyr61 in Urinary Tract Transitional Cell Carcinoma

Unknown status
  • Carcinoma, Transitional Cell
    • Banciao City, Taipei, Taiwan
      Far Eastern Memorial Hospital
    Oct 5, 2010

    Bladder Tumors, Ureteral Tumors, Urethral Tumors Trial in Baltimore, Cleveland, Seattle (TOCOSOL Paclitaxel)

    Completed
    • Bladder Neoplasms
    • +3 more
    • TOCOSOL Paclitaxel
    • Baltimore, Maryland
    • +2 more
    Jun 2, 2009

    Carcinoma, Transitional Cell, Bladder Tumors Trial in Canada, United States (Oncolytic adenovirus (serotype 5) - CG0070)

    Unknown status
    • Carcinoma, Transitional Cell
    • Bladder Neoplasms
    • Oncolytic adenovirus (serotype 5) - CG0070
    • Phoenix, Arizona
    • +9 more
    Oct 1, 2008

    Carcinoma, Transitional Cell Trial in Taipei (Lycopene)

    Withdrawn
    • Carcinoma, Transitional Cell
    • Taipei, Taiwan
      National Taiwan University Hospital
    Sep 25, 2008

    Bladder Tumors, Carcinoma, Transitional Cell Trial run by the NCI (suramin)

    Completed
    • Bladder Neoplasms
    • Carcinoma, Transitional Cell
    • Bethesda, Maryland
      National Cancer Institute (NCI)
    Mar 3, 2008

    Urologic Tumors, Carcinoma, Transitional Cell Trial in Japan (Gemcitabine)

    Completed
    • Urologic Neoplasms
    • Carcinoma, Transitional Cell
    • Fukuoka, Japan
    • +11 more
    Nov 5, 2007

    Carcinoma, Transitional Cell Trial in Villejuif (gemcitabine, oxaliplatin)

    Terminated
    • Carcinoma, Transitional Cell
    • gemcitabine, oxaliplatin
    • Villejuif, France
      Institut Gustave Roussy
    Aug 23, 2005